FIELD: medicine.
SUBSTANCE: it is described that immunogenicity of hemagglutinin (HA) molecule of influenza virus can be increased by substituting amino acids in the HA sequence. Substituting specific residues in HA such as asparagine introduction in position 223 in HA H5 allows ensuring more sensitive hemagglutination inhibition (HI) test provided by changing receptor specificity and/or ability to antibody-antigen linkage. The HA molecules having such substitutions can find application in creating diagnostic prototype viruses.
EFFECT: improved influenza virus vaccines.
9 cl, 3 dwg, 7 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED INFLUENZA VIRUS VACCINES | 2013 |
|
RU2552213C2 |
| METHOD TO APPLY MODIFIED FLU VIRUS | 2006 |
|
RU2480480C2 |
| IMMUNOGENIC EPITOPE OF INFLUENZA VIRUS | 2009 |
|
RU2546872C2 |
| COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1 | 2013 |
|
RU2639551C2 |
| RECOMBINANT PLASMID DNA pVL3-HA/H5 CARRYING INFLUENZA A (H5N8) VIRUS HEMAGGLUTININ GENE, A RECOMBINANT STRAIN OF CHINESE HAMSTER OVARY CELL LINE CHO-K1-H5 AND RECOMBINANT HEMAGGLUTININ OF INFLUENZA A (H5N8) VIRUS, PRODUCED BY CHO-K1-H5 STRAIN AND INTENDED FOR CREATION OF PREVENTIVE PREPARATIONS AND SEROLOGICAL DIAGNOSIS OF INFLUENZA A H5N8 VIRUS | 2024 |
|
RU2827202C1 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
| RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
| STRAIN OF INFLUENZA VIRUS GKV 2389 FOR PRODUCTION OF LIVING INTRANASAL AND INACTIVATED INFLUENZA VACCINE | 2006 |
|
RU2318871C1 |
| RECOMBINANT VIRUS-LIKE PARTICLES (VLP) USING BOVINE IMMUNODEFICIENCY VIRUS GROUP-SPECIFIC ANTIGEN (GAG) PROTEIN | 2016 |
|
RU2734118C2 |
| INFLUENZA VACCINE | 2011 |
|
RU2583297C2 |
